标题
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
作者
关键词
-
出版物
Advanced Science
Volume -, Issue -, Pages 1701036
出版商
Wiley
发表日期
2018-06-15
DOI
10.1002/advs.201701036
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer
- (2017) Kelli M. Luginbuhl et al. Nature Biomedical Engineering
- Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
- (2017) Sif Holmboe et al. PLoS One
- Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
- (2017) John T. Butterfield et al. Scientific Reports
- A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics
- (2016) Yan Pang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials
- (2016) S. S. Ramalingam et al. ANNALS OF ONCOLOGY
- PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery
- (2016) Yanyan Jiang et al. BIOMACROMOLECULES
- A Supramolecular Approach toward Bioinspired PAMAM-Dendronized Fusion Toxins
- (2016) Seah Ling Kuan et al. MACROMOLECULAR BIOSCIENCE
- Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
- (2016) João Conde et al. NATURE MATERIALS
- Modulation of RhoA GTPase Activity Sensitizes Human Cervix Carcinoma Cells toγ-Radiation by Attenuating DNA Repair Pathways
- (2016) Juliana H. Osaki et al. Oxidative Medicine and Cellular Longevity
- Water-soluble allyl sulfones for dual site-specific labelling of proteins and cyclic peptides
- (2016) Tao Wang et al. Chemical Science
- New Life for Immunotoxin Cancer Therapy
- (2015) R. Hassan et al. CLINICAL CANCER RESEARCH
- Approaches of targeting Rho GTPases in cancer drug discovery
- (2015) Yuan Lin et al. Expert Opinion on Drug Discovery
- Using combination therapy to thwart drug resistance
- (2015) Jessica A Hill et al. Future Microbiology
- Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions
- (2015) Holger Barth et al. Frontiers in Immunology
- Immunotoxins for leukemia
- (2014) A. S. Wayne et al. BLOOD
- Therapeutic strategies for neuroendocrine liver metastases
- (2014) Andrea Frilling et al. CANCER
- A Disulfide Intercalator Toolbox for the Site-Directed Modification of Polypeptides
- (2014) Tao Wang et al. CHEMISTRY-A EUROPEAN JOURNAL
- The chick embryo chorioallantoic membrane as a model for tumor biology
- (2014) Domenico Ribatti EXPERIMENTAL CELL RESEARCH
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
- (2014) João Conde et al. JOURNAL OF CONTROLLED RELEASE
- The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris
- (2014) Yuedi Ding et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- pH Responsive Janus-like Supramolecular Fusion Proteins for Functional Protein Delivery
- (2013) Seah Ling Kuan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multivalency of Non-Peptide Integrin αVβ3 Antagonist Slows Tumor Growth
- (2013) Yoo-Shin Kim et al. MOLECULAR PHARMACEUTICS
- C3 Rho-Inhibitor for Targeted Pharmacological Manipulation of Osteoclast-Like Cells
- (2013) Andrea Tautzenberger et al. PLoS One
- Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines
- (2013) M. Tontini et al. VACCINE
- RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
- (2013) Georgia Konstantinidou et al. Cancer Discovery
- Dendronized Albumin Core–Shell Transporters with High Drug Loading Capacity
- (2012) Seah Ling Kuan et al. BIOMACROMOLECULES
- Beyond Bevacizumab: Antiangiogenic Agents
- (2012) Shane Rogosin et al. Clinical Lung Cancer
- Stratified medicine for cancer therapy
- (2012) Emily C. Shaw et al. DRUG DISCOVERY TODAY
- DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
- (2011) J.-L. Li et al. CANCER RESEARCH
- Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans
- (2010) Fiorella Petronzelli et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Delivery of Therapeutic Proteins
- (2010) Dipak S. Pisal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
- (2010) S. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Somatostatin Receptor-Targeted Anti-Cancer Therapy
- (2010) Li-Chun Sun et al. Current Drug Delivery
- Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes
- (2009) Jörg Fahrer et al. CELLULAR MICROBIOLOGY
- Tirucallic Acids Are Novel Pleckstrin Homology Domain-Dependent Akt Inhibitors Inducing Apoptosis in Prostate Cancer Cells
- (2009) A. C. Estrada et al. MOLECULAR PHARMACOLOGY
- Janus-like Protein Cages. Spatially Controlled Dual-Functional Surface Modifications of Protein Cages
- (2009) Sebyung Kang et al. NANO LETTERS
- Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
- (2008) Sergey M. Deyev et al. BIOESSAYS
- Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
- (2008) M. Vogler et al. CANCER RESEARCH
- Chick Chorioallantoic Membrane as an In Situ Biological Membrane for Pharmaceutical Formulation Development: A Review
- (2008) Constance L. L. Saw et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Optimizing denileukin diftitox (Ontak®) therapy
- (2008) Madeleine Duvic et al. Future Oncology
- Activation of Nuclear Factor- B Pathway by Simvastatin and RhoA Silencing Increases Doxorubicin Cytotoxicity in Human Colon Cancer HT29 Cells
- (2008) C. Riganti et al. MOLECULAR PHARMACOLOGY
- PEGylation of cyanovirin–N, an entry inhibitor of HIV
- (2007) H. Zappe et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now